University of Alabama at Birmingham: Brain Neoplasms trials

The registry lists 12 Brain Neoplasms studies with University of Alabama at Birmingham as lead sponsor. 1 are open to participants now and 6 have results posted.

Early Phase 1 2Phase 1 6Phase 2 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Trial of Differential Margins in Single Isocenter Radiosurgery of Brain MetastasesRecruitingNCT06857006Not applicable
• Trial of C134 in Patients With Recurrent GBMCompletedNCT03657576Phase 1Results posted
• A Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain MetastasesCompletedNCT03412812Not applicableResults posted
• Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)TerminatedNCT02460874Phase 1/2Results posted
• Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant GliomaActive, not recruitingNCT02062827Phase 1Results posted
• Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With GliomaCompletedNCT01577966Not applicableResults posted
• Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain MetastasesCompletedNCT00582075Phase 2Results posted
• Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)TerminatedNCT06193174Phase 1
• FET-PET/MRI for Surgical Assessment of Pediatric Brain TumorsTerminatedNCT03451123Early Phase 1
• A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme PatientsCompletedNCT01770626Early Phase 1
• Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002)CompletedNCT01252797Phase 1
• A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma MultiformeCompletedNCT00584883Phase 1